Literature DB >> 6967870

The antibacterial activity of thienamycin against multiresistant bacteria-comparison with beta-lactamase stable compounds.

M F Romagnoli, K P Fu, H C Neu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6967870     DOI： 10.1093/jac/6.5.601

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

Review 1.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

2.  Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.

Authors:  S R Norrby; K Alestig; F Ferber; J L Huber; K H Jones; F M Kahan; M A Meisinger; J D Rogers
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

3.  Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients.

Authors:  B A Zajac; M A Fisher; G A Gibson; R R MacGregor
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

4.  Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791.

Authors:  H Gnarpe; J Belsheim; C Blomqvist; A Lundbäck
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

5.  Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.

Authors:  M D Reed; R C Stern; C A O'Brien; T S Yamashita; C M Myers; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 6.  Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?

Authors:  Federico Perez; Nadim G El Chakhtoura; Krisztina M Papp-Wallace; Brigid M Wilson; Robert A Bonomo
Journal:  Expert Opin Pharmacother       Date:  2016-03-09       Impact factor: 3.889

7.  Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography.

Authors:  C M Myers; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.